Morgan Stanley has downgraded Clarivate PLC (CLVT) to Underweight from Equal-Weight, reflecting a more cautious outlook for the company. As of December 16, 2025, Clarivate's shares are priced at $3.52, with a market capitalization of approximately $2.3 billion.
This downgrade underscores potential concerns about competitive pressures and market conditions that may impact the company's performance. Clarivate, which operates in the professional services sector, provides global information, analytics, and workflow solutions. Its offerings span multiple segments, including Academia & Government, Intellectual Property, and Life Sciences & Healthcare.
The company’s recent earnings performance shows mixed results, with an earnings per share (EPS) of -0.57 over the trailing twelve months. Upcoming earnings estimates indicate an EPS of $0.14 for April 27, 2026, and $0.19 for July 28, 2026, with revenue projections of $585.9 million and $620.2 million, respectively.
Analyst ratings and price targets offer insights based on research and financial models. However, they should be considered alongside various factors such as company fundamentals and industry trends. The current analyst consensus for Clarivate is categorized as Buy, with 3 Strong Buy, 4 Buy, and 7 Hold ratings among 15 analysts.
Analyst opinions can evolve as new information emerges, making it essential for investors to stay informed about changes in ratings and market dynamics.